Publications by authors named "Di-Hong Yang"
Article Synopsis
- Immunotherapy helps treat people with a type of lung cancer called non-small-cell lung cancer (NSCLC), but doctors are exploring combining it with chemotherapy to improve results.
- Researchers created a special computer model to study how a mix of three drugs works together for treating this cancer, which helps predict how well patients will respond to treatment.
- The model also found that certain types of immune cells in tumors can show how likely patients are to benefit from this combination therapy, making it easier for doctors to create personalized treatment plans.
Background: Pneumocystis jirovecii pneumonia (PCP) is an opportunistic infection with a difficult diagnosis, rapid progression, high mortality rate and poor prognosis. The primary treatment and prevention of PCP is trimethoprim/sulfamethoxazole (TMP/SMZ). However, there are many cases of intolerance or resistance to the drug, so the convenient and effective alternatives are deficient.
View Article and Find Full Text PDF